AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6387631 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's technique augmented with GSR biofeedback (biofeedback‐aided relaxation, BAR)
Number of subjects: 78
Study 6387631 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's relaxation technique (BRT)
Number of subjects: 78
Study 6387631 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 30786187 — intervention group
Group type: EXPERIMENTAL
Intervention: Plazomicin (15 mg per kilogram of body weight once daily)
Number of subjects: 609
Study 30786187 — intervention group
Group type: COMPARATOR
Intervention: Meropenem (1 g every 8 hours)
Number of subjects: 609
Study 29112869 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing a video game modeled from sensory foraging behavior
Number of subjects: 0
Study 29112869 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 27504543 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% trichloro‐acetic acid peel plus 5% topical magnesium ascorbyl phosphate
Number of subjects: 148
Study 27504543 — intervention group
Group type: COMPARATOR
Intervention: 20% trichloro‐acetic acid peel alone
Number of subjects: 148
Study 25250862 — intervention group
Group type: EXPERIMENTAL
Intervention: Transulnar intervention (TUI)
Number of subjects: 636
Study 25250862 — intervention group
Group type: COMPARATOR
Intervention: Transradial intervention (TRI)
Number of subjects: 636
Study 22789919 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (5-minute informational video and counseling about cataract, surgery, and surgical cost)
Number of subjects: 434
Study 22789919 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 434
Study 22789919 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 434
Study 19427744 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin 50 mg/m², Days 1 and 8; paclitaxel 175 mg/m² Day 1, every 21 days) followed by concurrent CRT (accelerated-hyperfractionated regimen, 45 Gy, 2 x 1.5 Gy/d, cisplatin 50 mg/m², Days 64 and 71, vinorelbine 20 mg/m², Days 64 and 71)
Number of subjects: 28
Study 19427744 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive radiotherapy (total dose 65 or 71 Gy, depending on the mean lung dose) with additional concurrent chemotherapy (cisplatin 40 mg/m², Day 85; vinorelbine 15 mg/m², Days 85 and 92)
Number of subjects: 28
Study 17513184 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal magnesium sulphate therapy
Number of subjects: 0
Study 17513184 — intervention group
Group type: COMPARATOR
Intervention: Control (no antenatal magnesium sulphate therapy)
Number of subjects: 0
Study 15627414 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor and verbal estimates of incline and azimuth from memory (Experiment 1)
Number of subjects: 0
Study 15627414 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor estimates of azimuth from memory under various conditions (Experiment 2)
Number of subjects: 0
Study 12013115 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar electrocautery scissors
Number of subjects: 40
Study 12013115 — intervention group
Group type: COMPARATOR
Intervention: Unipolar energy scalpel
Number of subjects: 40
Study 10450371 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg Retina Tomograph (HRT)
Number of subjects: 81
Study 7786657 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 2.5-10 mg twice daily
Number of subjects: 252
Study 7786657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 7786657 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 252
Study 1536276 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 7
Study 1536276 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 7
Study 1536276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 6504944 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline ('Trental' 400) 400 mg (2 tablets)
Number of subjects: 9
Study 6504944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30451531 — intervention group
Group type: EXPERIMENTAL
Intervention: Light force (300 g) CHG
Number of subjects: 40
Study 30451531 — intervention group
Group type: COMPARATOR
Intervention: Heavy force (500 g) CHG
Number of subjects: 40
Study 30451531 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 30100129 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot sand fomentation (HSF) added to yoga and sesame seed oil application
Number of subjects: 60
Study 30100129 — intervention group
Group type: COMPARATOR
Intervention: Yoga and sesame seed oil application (Control)
Number of subjects: 60
Study 26484518 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice and physical practice gait protocol (N=10)
Number of subjects: 20
Study 26484518 — intervention group
Group type: COMPARATOR
Intervention: Physical practice (N=10)
Number of subjects: 20
Study 23691836 — intervention group
Group type: EXPERIMENTAL
Intervention: Error-encouragement training
Number of subjects: 164
Study 23691836 — intervention group
Group type: COMPARATOR
Intervention: Error-avoidance training
Number of subjects: 164
Study 23691836 — intervention group
Group type: COMPARATOR
Intervention: Control training
Number of subjects: 164
Study 21762789 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Home‐based Intervention Package (improved stoves, kitchen sinks, hand washing promotion, solar drinking water disinfection)
Number of subjects: 534
Study 21762789 — intervention group
Group type: COMPARATOR
Intervention: Psychomotor stimulation intervention (Control)
Number of subjects: 534
Study 19336462 — intervention group
Group type: EXPERIMENTAL
Intervention: Amusic subjects
Number of subjects: 0
Study 19336462 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 0
Study 16493167 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block with ropivacaine and oral hydrocodone
Number of subjects: 90
Study 16493167 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection of bupivacaine/morphine and oral oxycodone
Number of subjects: 90
Study 14595562 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Training (HIT)
Number of subjects: 6
Study 14595562 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Endurance Training (ET)
Number of subjects: 6
Study 11787715 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 visits during pregnancy and early postpartum
Number of subjects: 130
Study 11787715 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 visits during pregnancy and early postpartum
Number of subjects: 130
Study 11787715 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 130
Study 11787715 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (3 visits and 6 visits combined)
Number of subjects: 130
Study 9072885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplementation (Actiferrin, 3 x 1 cps/d, 724.5 mg elemental Fe per week)
Number of subjects: 61
Study 9072885 — intervention group
Group type: COMPARATOR
Intervention: Intravenous iron supplementation (Ferrum-Lek, 1 vial per week, 100 mg elemental iron per week)
Number of subjects: 61
Study 1306677 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimu-gum device
Number of subjects: 64
Study 1306677 — intervention group
Group type: COMPARATOR
Intervention: Oral-B 35 manual toothbrush
Number of subjects: 64
Study 3866334 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA 5% cream
Number of subjects: 30
Study 3866334 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine 5% ointment
Number of subjects: 30
Study 3866334 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 30
Study 3866334 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry EMLA emulsion in cellulose discs
Number of subjects: 30
Study 3866334 — intervention group
Group type: COMPARATOR
Intervention: Placebo discs
Number of subjects: 30
Study 31106886 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (n=57)
Number of subjects: 115
Study 31106886 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (n=58)
Number of subjects: 115
Study 30249900 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI with 5‐FU followed by UFT/LV (Arm A)
Number of subjects: 44
Study 30249900 — intervention group
Group type: COMPARATOR
Intervention: UFT/LV alone (Arm B)
Number of subjects: 44
Study 26626617 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 68
Study 26626617 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 68
Study 25022705 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of IPL-F and LF-QS-Nd:YAG laser
Number of subjects: 24
Study 25022705 — intervention group
Group type: COMPARATOR
Intervention: IPL-F alone (control group)
Number of subjects: 24
Study 22040598 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary patterns in mothers: 'Fruits and vegetables', 'High-energy snack and processed foods', 'High-fat foods', 'Cereals and sweet foods'
Number of subjects: 454
Study 22040598 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary patterns in fathers: 'Fruits', 'High-energy snack and processed foods', 'High-fat foods', 'Potatoes and vegetables'
Number of subjects: 454
Study 22040598 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between dietary patterns of mothers and fathers
Number of subjects: 454
Study 21438412 — intervention group
Group type: EXPERIMENTAL
Intervention: Naoxinduotai capsule + perindopril
Number of subjects: 62
Study 21438412 — intervention group
Group type: COMPARATOR
Intervention: Perindopril
Number of subjects: 62
Study 17564200 — intervention group
Group type: EXPERIMENTAL
Intervention: Body tilt at 135 degrees
Number of subjects: 0
Study 17564200 — intervention group
Group type: COMPARATOR
Intervention: Body tilt at 0, 45, 90 degrees, and 180 degrees
Number of subjects: 0
Study 16043156 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumina intense pulsed light system
Number of subjects: 12
Study 12107665 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 640
Study 12107665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study 12107665 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily (stratified by age 64 years)
Number of subjects: 640
Study 12107665 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily (stratified by age 76 years)
Number of subjects: 640
Study 10023618 — intervention group
Group type: EXPERIMENTAL
Intervention: Network Therapy (NT)
Number of subjects: 30
Study 10023618 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study 7581086 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506 (0.05 mg/kg i.v. or 0.15 mg/kg orally twice a day)
Number of subjects: 49
Study 7581086 — intervention group
Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 49
Study 1698845 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous antigen challenge
Number of subjects: 20
Study 1698845 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of 1 mg/kg methylprednisolone
Number of subjects: 20
Study 1698845 — intervention group
Group type: COMPARATOR
Intervention: Codeine challenge
Number of subjects: 20
Study 1698845 — intervention group
Group type: COMPARATOR
Intervention: Intermittent antigen challenge
Number of subjects: 20
Study 417377 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular loxapine
Number of subjects: 10
Study 417377 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral loxapine
Number of subjects: 10
Study 31738406 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular home visits by a nurse
Number of subjects: 80
Study 31743569 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin (50 mg, once daily)
Number of subjects: 161
Study 31743569 — intervention group
Group type: COMPARATOR
Intervention: Placebo (initially) then switched to Ipragliflozin (50 mg, once daily)
Number of subjects: 161
Study 28727771 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised high intensity exercise program
Number of subjects: 109
Study 28727771 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 109
Study 26124797 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training and dietary measures
Number of subjects: 100
Study 26124797 — intervention group
Group type: COMPARATOR
Intervention: No training intervention
Number of subjects: 100
Study 22770818 — intervention group
Group type: EXPERIMENTAL
Intervention: Single sterile water injection (n=147)
Number of subjects: 305
Study 22770818 — intervention group
Group type: COMPARATOR
Intervention: Four sterile water injections (n=158)
Number of subjects: 305
Study 20680312 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous suturing technique
Number of subjects: 160
Study 20680312 — intervention group
Group type: COMPARATOR
Intervention: Interrupted suturing technique
Number of subjects: 160
Study 20396720 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of artrofoon and anaferon
Number of subjects: 0
Study 17185130 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl/15% EDTA
Number of subjects: 26
Study 17185130 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.3% NaOCl/BioPure MTAD
Number of subjects: 26
Study 15114907 — intervention group
Group type: EXPERIMENTAL
Intervention: Two types of judgment combined with two stimulus dimensions
Number of subjects: 0
Study 15114907 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of two types of judgment with two stimulus dimensions
Number of subjects: 0
Study 11557191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine (100 mg/day)
Number of subjects: 31
Study 11557191 — intervention group
Group type: COMPARATOR
Intervention: Folate (5 mg/day)
Number of subjects: 31
Study 11557191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 9590462 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg taken orally once daily for 7 consecutive days
Number of subjects: 20
Study 9590462 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan administration on day 1
Number of subjects: 20
Study 9590462 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan administration on day 7
Number of subjects: 20
Study 7599468 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline (experimental group)
Number of subjects: 152
Study 7599468 — intervention group
Group type: COMPARATOR
Intervention: Heparinised saline (control group)
Number of subjects: 152
Study 7599468 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of i.v. antibiotics tobramycin
Number of subjects: 152
Study 7599468 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of i.v. antibiotics Timentin
Number of subjects: 152
Study 7599468 — intervention group
Group type: EXPERIMENTAL
Intervention: Flushing solution (both normal saline and heparinised saline)
Number of subjects: 152
Study 3279997 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance melphalan and prednisone (MP)
Number of subjects: 185
Study 3279997 — intervention group
Group type: COMPARATOR
Intervention: No maintenance treatment (stopping MP)
Number of subjects: 185
Study 28069992 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education programme
Number of subjects: 706
Study 28069992 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 706
Study 27999850 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Lecithin, 2400 mg daily)
Number of subjects: 24
Study 27999850 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (eicosapentaenoic acid (EPA); 1770 mg, and docosahexaenoic acid (DHA); 390 mg, daily)
Number of subjects: 24
Study 27999850 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (1,000 IU daily)
Number of subjects: 24
Study 25574715 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% Acacia nilotica
Number of subjects: 90
Study 25574715 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine (active control)
Number of subjects: 90
Study 25574715 — intervention group
Group type: COMPARATOR
Intervention: saline water (passive control)
Number of subjects: 90
Study 23791619 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg MK-7123
Number of subjects: 31
Study 23791619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 20009942 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo refractometry using lotrafilcon B lens
Number of subjects: 9
Study 20009942 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo refractometry using etafilcon A lens
Number of subjects: 9
Study 20009942 — intervention group
Group type: COMPARATOR
Intervention: Ex vivo refractometry using lotrafilcon B lens
Number of subjects: 9
Study 20009942 — intervention group
Group type: COMPARATOR
Intervention: Ex vivo refractometry using etafilcon A lens
Number of subjects: 9
Study 20009942 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical significance for etafilcon A lens
Number of subjects: 9
Study 20009942 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical significance for lotrafilcon B lens
Number of subjects: 9
Study 18198223 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate beverages
Number of subjects: 16
Study 18198223 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein beverages
Number of subjects: 16
Study 18198223 — intervention group
Group type: COMPARATOR
Intervention: Lipid beverages
Number of subjects: 16
Study 16169314 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel in addition to low- to moderate-dose aspirin
Number of subjects: 15603
Study 16169314 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to low- to moderate-dose aspirin
Number of subjects: 15603
Study 14582907 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-burst oxygen therapy (SBOT) before exercise
Number of subjects: 22
Study 14582907 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-burst oxygen therapy (SBOT) after exercise
Number of subjects: 22
Study 14582907 — intervention group
Group type: COMPARATOR
Intervention: Air (control) before exercise
Number of subjects: 22
Study 14582907 — intervention group
Group type: COMPARATOR
Intervention: Air (control) after exercise
Number of subjects: 22
Study 10577444 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration of ACE inhibitor dosage according to serial measurement of plasma BNP concentration (BNP group)
Number of subjects: 20
Study 10577444 — intervention group
Group type: COMPARATOR
Intervention: Optimal empirical ACE inhibitor therapy (clinical group)
Number of subjects: 20
Study 8735314 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive pill
Number of subjects: 5
Study 1753161 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom limited exercise test (ET) performed before discharge
Number of subjects: 0
Study 1753161 — intervention group
Group type: COMPARATOR
Intervention: Symptom limited exercise test (ET) performed after one month
Number of subjects: 0
Study 1753161 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ETs (before discharge and after one month)
Number of subjects: 0
Study 1753161 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom limited ET performed before discharge
Number of subjects: 0
Study 7459218 — intervention group
Group type: EXPERIMENTAL
Intervention: Good-prognosis group (BUC <= 8 mM, [Hb] >= 100 g/l, no or minimal symptoms)
Number of subjects: 485
Study 7459218 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate prognosis group (combinations of determinant features excluding good and poor prognosis)
Number of subjects: 485
Study 7459218 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor-prognosis group ([Hb] <= 75 g/l or BUC > 10 mM and restricted clinical activity)
Number of subjects: 485
Study 7459218 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival probabilities for prognostic groups
Number of subjects: 485
Study 31108814 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized oligopeptides; specific peptides synthesized for confirmation and quantification; details on dosage and duration not available.
Number of subjects: 0
Study 31108814 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteinase cleavage site analysis; no specific intervention mentioned.
Number of subjects: 0
Study 27796575 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered Toothbrush (PT)
Number of subjects: 110
Study 27796575 — intervention group
Group type: COMPARATOR
Intervention: Manual Toothbrush (MT)
Number of subjects: 110
Study 25870998 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar energy (Group 1)
Number of subjects: 124
Study 25870998 — intervention group
Group type: COMPARATOR
Intervention: Bipolar energy (Group 2)
Number of subjects: 124
Study 25870998 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar energy (Group 1) among CP patients
Number of subjects: 124
Study 25870998 — intervention group
Group type: COMPARATOR
Intervention: Bipolar energy (Group 2) among CP patients
Number of subjects: 124
Study 25870998 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar energy (Group 1) among BPH patients
Number of subjects: 124
Study 25870998 — intervention group
Group type: COMPARATOR
Intervention: Bipolar energy (Group 2) among BPH patients
Number of subjects: 124
Study 23478479 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration and Stretching (VS)
Number of subjects: 21
Study 23478479 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Only (VO)
Number of subjects: 21
Study 23478479 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching Only (SO)
Number of subjects: 21
Study 21168981 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic disease management (CDM) care
Number of subjects: 282
Study 19185687 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided CBD stone removal
Number of subjects: 52
Study 19185687 — intervention group
Group type: COMPARATOR
Intervention: ERCP-guided CBD stone removal
Number of subjects: 52
Study 16393735 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (25/50 mg dd.) combined with nicotine replacement therapy (NRT) and Community Reinforcement Approach (CRA)
Number of subjects: 25